title: Neutralization of lipopolysaccharide effects in liver diseases, the quest for the Holy Grail.
authors.forename: Arnaud
authors.initials: A
authors.lastname: Galbois
authors.forename: Dominique
authors.initials: D
authors.lastname: Thabut
authors.forename: Richard
authors.initials: R
authors.lastname: Moreau
authors.forename: Didier
authors.initials: D
authors.lastname: Lebrec
mesh_terms: D006801:Humans; D015850:Interleukin-6 / Q000378:metabolism; D008070:Lipopolysaccharides / Q000097:blood*; D008075:Lipoproteins, HDL / Q000097:blood; D008107:Liver Diseases / Q000097:blood / Q000503:physiopathology*; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism
chemical_list: D015850:Interleukin-6; D008070:Lipopolysaccharides; D008075:Lipoproteins, HDL; D014409:Tumor Necrosis Factor-alpha